Detalhe da pesquisa
1.
Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers.
Sci Adv
; 9(44): eadh4379, 2023 11 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37910620
2.
A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy.
JCI Insight
; 7(22)2022 11 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36509287
3.
DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas.
Mol Ther Oncolytics
; 24: 218-229, 2022 Mar 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35071745
4.
In vivo DNA-launched bispecific T cell engager targeting IL-13Rα2 controls tumor growth in an animal model of glioblastoma multiforme.
Mol Ther Oncolytics
; 26: 289-301, 2022 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36090479
5.
A synDNA vaccine delivering neoAg collections controls heterogenous, multifocal murine lung and ovarian tumors via robust T cell generation.
Mol Ther Oncolytics
; 21: 278-287, 2021 Jun 25.
Artigo
Inglês
| MEDLINE | ID: mdl-34141866
6.
Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer.
Sci Transl Med
; 11(479)2019 02 13.
Artigo
Inglês
| MEDLINE | ID: mdl-30760579
7.
Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer.
Cancer Cell
; 30(1): 120-135, 2016 07 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27374224
8.
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer.
J Clin Invest
; 124(12): 5466-80, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25384214